Cargando…
Abatacept enhances blood regulatory B cells of rheumatoid arthritis patients to a level that associates with disease remittance
Abatacept, an inhibitor of CD28 mediated T-cell activation, has been shown to be effective in controlling inflammation during rheumatoid arthritis (RA). However, its effects on immune regulatory B and T cells (Bregs and Tregs) has not been fully explored. Thirty-one RA patients treated with abatacep...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952390/ https://www.ncbi.nlm.nih.gov/pubmed/33707483 http://dx.doi.org/10.1038/s41598-021-83615-0 |